Literature DB >> 32111391

Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD study.

Claudio Babiloni1, Susanna Lopez2, Claudio Del Percio3, Giuseppe Noce4, Maria Teresa Pascarelli5, Roberta Lizio4, Stefan J Teipel6, Gabriel González-Escamilla7, Hovagim Bakardjian8, Nathalie George9, Enrica Cavedo10, Simone Lista10, Patrizia Andrea Chiesa10, Andrea Vergallo11, Pablo Lemercier10, Giuseppe Spinelli8, Michel J Grothe12, Marie-Claude Potier13, Fabrizio Stocchi14, Raffaele Ferri5, Marie-Odile Habert15, Francisco J Fraga16, Bruno Dubois8, Harald Hampel11.   

Abstract

Cognitive reserve is present in Alzheimer's disease (AD) seniors with high education attainment making them clinically resilient to extended brain neuropathology and neurodegeneration. Here, we tested whether subjective memory complaint (SMC) seniors with AD neuropathology and high education attainment of the prospective INSIGHT-preAD cohort (Paris) may present abnormal eyes-closed resting state posterior electroencephalographic rhythms around individual alpha frequency peak, typically altered in AD patients. The SMC participants negative to amyloid PET AD markers (SMCneg) with high (over low-moderate) education level showed higher posterior alpha 2 power density (possibly "neuroprotective"). Furthermore, amyloid PET-positive SMC (SMCpos) participants with high (over low-moderate) education level showed higher temporal alpha 3 power density (possibly "neuroprotective") and lower posterior alpha 2 power density (possibly "compensatory"). This effect may reflect cognitive reserve as no differences in brain gray-white matter, and cognitive functions were observed between these SMCpos/SMCneg subgroups. Preclinical Alzheimer's neuropathology may interact with education attainment and neurophysiological mechanisms generating cortical alpha rhythms around individual alpha frequency peak (i.e., alpha 2 and 3) in quiet wakefulness.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha rhythms; INSIGHT-preAD study; Preclinical Alzheimer's disease (AD); Preclinical Alzheimer's neuropathology; Resting state EEG rhythms; Subjective memory complaint (SMC)

Year:  2020        PMID: 32111391     DOI: 10.1016/j.neurobiolaging.2020.01.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Alpha desynchronization during Stroop test unmasks cognitively healthy individuals with abnormal CSF Amyloid/Tau.

Authors:  Xianghong Arakaki; Shao-Min Hung; Roger Rochart; Alfred N Fonteh; Michael G Harrington
Journal:  Neurobiol Aging       Date:  2021-12-05       Impact factor: 4.673

Review 2.  Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.

Authors:  Claudio Babiloni; Xianghong Arakaki; Hamed Azami; Karim Bennys; Katarzyna Blinowska; Laura Bonanni; Ana Bujan; Maria C Carrillo; Andrzej Cichocki; Jaisalmer de Frutos-Lucas; Claudio Del Percio; Bruno Dubois; Rebecca Edelmayer; Gary Egan; Stephane Epelbaum; Javier Escudero; Alan Evans; Francesca Farina; Keith Fargo; Alberto Fernández; Raffaele Ferri; Giovanni Frisoni; Harald Hampel; Michael G Harrington; Vesna Jelic; Jaeseung Jeong; Yang Jiang; Maciej Kaminski; Voyko Kavcic; Kerry Kilborn; Sanjeev Kumar; Alice Lam; Lew Lim; Roberta Lizio; David Lopez; Susanna Lopez; Brendan Lucey; Fernando Maestú; William J McGeown; Ian McKeith; Davide Vito Moretti; Flavio Nobili; Giuseppe Noce; John Olichney; Marco Onofrj; Ricardo Osorio; Mario Parra-Rodriguez; Tarek Rajji; Petra Ritter; Andrea Soricelli; Fabrizio Stocchi; Ioannis Tarnanas; John Paul Taylor; Stefan Teipel; Federico Tucci; Mitchell Valdes-Sosa; Pedro Valdes-Sosa; Marco Weiergräber; Gorsev Yener; Bahar Guntekin
Journal:  Alzheimers Dement       Date:  2021-04-15       Impact factor: 16.655

3.  Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects.

Authors:  Wei Yin; Fahimeh Mamashli; Derek L Buhl; Polyna Khudyakov; Dmitri Volfson; Ferenc Martenyi; Hakop Gevorkyan; Laura Rosen; Arthur A Simen
Journal:  Br J Clin Pharmacol       Date:  2021-07-31       Impact factor: 3.716

4.  Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.

Authors:  Amir H Meghdadi; Marija Stevanović Karić; Marissa McConnell; Greg Rupp; Christian Richard; Joanne Hamilton; David Salat; Chris Berka
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

5.  Magnetoencephalography Brain Signatures Relate to Cognition and Cognitive Reserve in the Oldest-Old: The EMIF-AD 90 + Study.

Authors:  Alessandra Griffa; Nienke Legdeur; Maryam Badissi; Martijn P van den Heuvel; Cornelis J Stam; Pieter Jelle Visser; Arjan Hillebrand
Journal:  Front Aging Neurosci       Date:  2021-11-25       Impact factor: 5.750

6.  Resting-state electroencephalographic correlates of cognitive reserve: Moderating the age-related worsening in cognitive function.

Authors:  Ana Buján; Adriana Sampaio; Diego Pinal
Journal:  Front Aging Neurosci       Date:  2022-09-14       Impact factor: 5.702

7.  Verbal intelligence and leisure activities are associated with cognitive performance and resting-state electroencephalogram.

Authors:  Martina Ferrari-Díaz; Ricardo Iván Bravo-Chávez; Juan Silva-Pereyra; Thalía Fernández; Carmen García-Peña; Mario Rodríguez-Camacho
Journal:  Front Aging Neurosci       Date:  2022-10-04       Impact factor: 5.702

Review 8.  Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.

Authors:  Frédérique K Kok; Suzanne L van Leerdam; Elizabeth C M de Lange
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

9.  Compromised Behavior and Gamma Power During Working Memory in Cognitively Healthy Individuals With Abnormal CSF Amyloid/Tau.

Authors:  Roger Rochart; Quanying Liu; Alfred N Fonteh; Michael G Harrington; Xianghong Arakaki
Journal:  Front Aging Neurosci       Date:  2020-10-14       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.